An Important Factor Driving the Scleritis Market Is the Impact Of Rising Autoimmune Disease Prevalence On Ocular Inflammation

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Expansion Is Predicted For The Scleritis Market Between 2026 And 2030?

The scleritis market has experienced significant growth in recent years. It is projected to increase from $3.93 billion in 2025 to $4.28 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.9%. This historic growth can be linked to factors such as the rising prevalence of autoimmune disorders, the application of corticosteroids in ocular therapy, the availability of immunosuppressive agents, an increasing number of ophthalmology clinics, and growing awareness of ocular inflammatory diseases.

The scleritis market size is projected to experience substantial growth over the coming years, reaching $5.95 billion in 2030 with a compound annual growth rate (CAGR) of 8.6%. This expansion during the forecast period is primarily driven by an active pipeline of biologic medications for ocular inflammation, the increasing uptake of teleophthalmology platforms, advancements in targeted anti-inflammatory treatments, improved accessibility to sophisticated imaging methods, and the broadening scope of rare eye disease awareness initiatives. Furthermore, significant market trends anticipated during this period encompass the widening application of biologic treatments for ocular inflammation, a surge in the utilization of corticosteroids and immunosuppressant agents, the increasing embrace of combination therapy strategies, a heightened emphasis on early diagnosis and diagnostic imaging, and the creation of new anti-inflammatory ophthalmic pharmaceutical products.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21283&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Scleritis Market?

The increasing occurrence of autoimmune conditions is projected to fuel the expansion of the scleritis market in the future. These conditions arise when the body’s own immune defenses mistakenly target and damage its healthy cells and tissues, perceiving them as threats. The growing incidence of autoimmune diseases is attributed to factors such as genetic susceptibility, environmental influences, shifts in lifestyle, and improved diagnostic capabilities resulting from greater awareness. Autoimmune disorders contribute to scleritis by initiating an inflammatory immune reaction that erroneously attacks the scleral tissue, leading to symptoms like pain and redness. As an illustration, in August 2024, data released by Public Health Scotland, a national organization based in Scotland, indicated that during 2023, the Scottish Multiple Sclerosis Register (SMSR) registered 455 individuals newly diagnosed with MS. Consequently, the escalating prevalence of autoimmune diseases is propelling the growth of the scleritis market.

Which Market Segments Are Examined In The Scleritis Market Study?

The scleritis market covered in this report is segmented –

1) By Type: Anterior Scleritis, Posterior Scleritis, Other Types

2) By Treatment: Medication, Surgery, Other Treatment

3) By Distribution Channel: Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channel

4) By End-Users: Hospitals, Specialty Clinics, Home Healthcare, Other End-Users

Subsegments:

1) By Anterior Scleritis: Non-Necrotizing Anterior Scleritis, Necrotizing Anterior Scleritis

2) By Posterior Scleritis: Diffuse Posterior Scleritis, Nodular Posterior Scleritis, Scleritis With Choroidal Involvement

3) By Other Types: Chronic Scleritis, Recurrent Scleritis, Infectious Scleritis

How Are Trends Shaping The Direction Of The Scleritis Market?

Key companies operating within the scleritis market are concentrating on developing advanced products, such as eye drops, to address the underlying inflammation and offer practical, non-invasive treatment alternatives for patients. Eye drops are fluid preparations designed for direct application to the eyes to manage issues like irritation, dryness, inflammation, or infections. For example, in May 2023, Entod Pharmaceuticals, an India-based pharmaceutical company, launched CYCLOTEARS eye drops across India and globally. This novel therapeutic option for inflammatory eye disease incorporates proprietary SEDDS technology. This product enhances drug delivery and effectiveness, providing an innovative approach to manage inflammation in DED. This innovation signifies a major progression in the treatment of eye inflammation, ocular myositis, and scleritis.

Who Are The Primary Competitors In The Scleritis Market?

Major companies operating in the scleritis market are Pfizer Inc, Johnson And Johnson, F Hoffmann La Roche Ltd, Bayer AG, Novartis AG, Teva Pharmaceuticals USA Inc, Baxter International Inc, Boehringer Ingelheim, Regeneron Pharmaceuticals Inc, Fresenius Kabi USA LLC, Sun Pharmaceutical Industries Ltd, Perrigo Company, Horizon Therapeutics plc, Aurobindo Pharma Ltd, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Mallinckrodt Pharmaceuticals, Alvogen, Accord Healthcare, West Ward Pharmaceuticals, Jubilant Cadista Pharmaceuticals Inc, Mylan Pharmaceuticals Inc, Zydus Pharmaceuticals Inc

Read the full scleritis market report here:

https://www.thebusinessresearchcompany.com/report/scleritis-global-market-report

What Are The Leading Geographic Regions In The Scleritis Market?

North America was the largest region in the scleritis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the scleritis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Scleritis Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21283&type=smp

Browse Through More Reports Similar to the Global Scleritis Market 2026, By The Business Research Company

Dermatitis Drugs Global Market Report

https://www.thebusinessresearchcompany.com/report/dermatitis-drugs-global-market-report

Knee Bursitis Global Market Report

https://www.thebusinessresearchcompany.com/report/knee-bursitis-global-market-report

Bacterial Conjunctivitis Global Market Report

https://www.thebusinessresearchcompany.com/report/bacterial-conjunctivitis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795